USA —Advisers to the U.S. Food and Drug Administration gave strong support for full approval of Pfizer’s oral antiviral COVID-19 treatment, Paxlovid, for adults at…
NETHERLANDS — Merck is appealing the EMA’s rejection of its Covid-19 pill, Lagevrio, which serves as an alternative to Pfizer’s Paxlovid. The EMA stated that…
AFRICA – European Union-funded, WHO-led two-year project has risen the number of COVID-19 vaccination in many vulnerable African communities. At the start of 2022, the…
USA—IQVIA’s latest report on the biopharmaceutical industry shows that it has rebounded from the COVID-19 pandemic and is returning to pre-pandemic levels of investment, pipeline…
NETHERLANDS — Merck and Ridgeback Biotherapeutics’ COVID-19 pill Lagevrio has been recommended against approval by a key committee of the European Medicines Agency (EMA). The…
AUSTRALIA — University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the…
NIGERIA – Nigeria, with the support of Gavi, the Vaccine Alliance, has surpassed the milestone of fully vaccinating 30 per cent of its total population.…
USA — Evusheld, a preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization in the United States because it is unlikely to…
SIERRA LEONE – Government of Sierra Leone has received vehicles including motorbikes and computers worth over US$2.8 million from the COVID-19 Vaccine Delivery Partnership, (CoVDP),…
NIGERIA – The Nigerian government has announced that international travellers to Nigeria are now required to show evidence of COVID-19 vaccination. This follows the recent…